Lentinan enhances CAR-T cell potency in solid tumors by optimizing T cell differentiation
CAR-T cell therapy has demonstrated remarkable success in treating hematologic malignancies; however, its efficacy in solid tumors remains constrained. In this study, we demonstrate that Lentinan (LTN), an active polysaccharide derived from Lentinula edodes, potently enhances CAR-T cell function aga...
Saved in:
| Main Authors: | Xiangyun Niu, Pengchao Zhang, Zhongming Liu, Yexiao Tang, Shu Xu, Xiaochun Wan, Zhiming Xu, Guizhong Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1605488/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Unlocking Apoptotic Pathways: Overcoming Tumor Resistance in CAR‐T‐Cell Therapy
by: Zhanna Zhang, et al.
Published: (2024-10-01) -
The Potential Use of Digital Twin Technology for Advancing CAR-T Cell Therapy
by: Sara Sadat Aghamiri, et al.
Published: (2025-04-01) -
Assessment of the Adjuvant Effects of Lentinan on the Tuberculosis Subunit Vaccine BG
by: Shuai Zhou, et al.
Published: (2025-05-01) -
Reprogramming CAR-T cells: Targeting SLC transporters for tumor microenvironment adaptation
by: Beatriz Perucha, et al.
Published: (2025-10-01) -
Application and prospects of genetic engineering in CAR-NK cell therapy
by: Caidong Hu, et al.
Published: (2025-05-01)